Literature DB >> 25970457

Prevention: Tending the gut.

Lauren Gravitz.   

Abstract

Mesh:

Substances:

Year:  2015        PMID: 25970457     DOI: 10.1038/521S6a

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  5 in total

1.  Opportunities for the primary prevention of colorectal cancer in the United States.

Authors:  Corinne E Joshu; Giovanni Parmigiani; Graham A Colditz; Elizabeth A Platz
Journal:  Cancer Prev Res (Phila)       Date:  2011-09-28

2.  Association of aspirin and NSAID use with risk of colorectal cancer according to genetic variants.

Authors:  Hongmei Nan; Carolyn M Hutter; Yi Lin; Eric J Jacobs; Cornelia M Ulrich; Emily White; John A Baron; Sonja I Berndt; Hermann Brenner; Katja Butterbach; Bette J Caan; Peter T Campbell; Christopher S Carlson; Graham Casey; Jenny Chang-Claude; Stephen J Chanock; Michelle Cotterchio; David Duggan; Jane C Figueiredo; Charles S Fuchs; Edward L Giovannucci; Jian Gong; Robert W Haile; Tabitha A Harrison; Richard B Hayes; Michael Hoffmeister; John L Hopper; Thomas J Hudson; Mark A Jenkins; Shuo Jiao; Noralane M Lindor; Mathieu Lemire; Loic Le Marchand; Polly A Newcomb; Shuji Ogino; Bethann M Pflugeisen; John D Potter; Conghui Qu; Stephanie A Rosse; Anja Rudolph; Robert E Schoen; Fredrick R Schumacher; Daniela Seminara; Martha L Slattery; Stephen N Thibodeau; Fridtjof Thomas; Mark Thornquist; Greg S Warnick; Brent W Zanke; W James Gauderman; Ulrike Peters; Li Hsu; Andrew T Chan
Journal:  JAMA       Date:  2015-03-17       Impact factor: 56.272

3.  Vegetarian dietary patterns and the risk of colorectal cancers.

Authors:  Michael J Orlich; Pramil N Singh; Joan Sabaté; Jing Fan; Lars Sveen; Hannelore Bennett; Synnove F Knutsen; W Lawrence Beeson; Karen Jaceldo-Siegl; Terry L Butler; R Patti Herring; Gary E Fraser
Journal:  JAMA Intern Med       Date:  2015-05       Impact factor: 21.873

4.  MUC1 vaccine for individuals with advanced adenoma of the colon: a cancer immunoprevention feasibility study.

Authors:  Takashi Kimura; John R McKolanis; Lynda A Dzubinski; Kazi Islam; Douglas M Potter; Andres M Salazar; Robert E Schoen; Olivera J Finn
Journal:  Cancer Prev Res (Phila)       Date:  2012-12-17

5.  Difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas: a randomized placebo-controlled, double-blind trial.

Authors:  Frank L Meyskens; Christine E McLaren; Daniel Pelot; Sharon Fujikawa-Brooks; Philip M Carpenter; Ernest Hawk; Gary Kelloff; Michael J Lawson; Jayashri Kidao; John McCracken; C Gregory Albers; Dennis J Ahnen; D Kim Turgeon; Steven Goldschmid; Peter Lance; Curt H Hagedorn; Daniel L Gillen; Eugene W Gerner
Journal:  Cancer Prev Res (Phila)       Date:  2008-06
  5 in total
  7 in total

Review 1.  GUCY2C ligand replacement to prevent colorectal cancer.

Authors:  Erik S Blomain; Amanda M Pattison; Scott A Waldman
Journal:  Cancer Biol Ther       Date:  2016-04-22       Impact factor: 4.742

Review 2.  Physical Activity and Nutrition in Primary and Tertiary Prevention of Colorectal Cancer.

Authors:  Michael H Schoenberg
Journal:  Visc Med       Date:  2016-06-08

3.  Circ-0001313/miRNA-510-5p/AKT2 axis promotes the development and progression of colon cancer.

Authors:  Fang-Ling Tu; Xi-Qing Guo; Hai-Xia Wu; Zhi-Yun He; Fang Wang; Ai-Jun Sun; Xu-Dong Dai
Journal:  Am J Transl Res       Date:  2020-01-15       Impact factor: 4.060

4.  Morning breathing exercises prolong lifespan by improving hyperventilation in people living with respiratory cancer.

Authors:  Wei-Jie Wu; Shan-Huan Wang; Wei Ling; Li-Jun Geng; Xiao-Xi Zhang; Lan Yu; Jun Chen; Jiang-Xi Luo; Hai-Lu Zhao
Journal:  Medicine (Baltimore)       Date:  2017-01       Impact factor: 1.889

Review 5.  Targeting KRAS in metastatic colorectal cancer: current strategies and emerging opportunities.

Authors:  Manuela Porru; Luca Pompili; Carla Caruso; Annamaria Biroccio; Carlo Leonetti
Journal:  J Exp Clin Cancer Res       Date:  2018-03-13

6.  Aberrant KIF23 expression is associated with adverse clinical outcome and promotes cellular malignant behavior through the Wnt/β-catenin signaling pathway in Colorectal Cancer.

Authors:  Zhiyu Ji; Aoning Mi; Mengmeng Li; Quanying Li; Changjiang Qin
Journal:  J Cancer       Date:  2021-02-02       Impact factor: 4.207

7.  Sevoflurane Suppresses Colon Cancer Cell Malignancy by Regulating circ-PI4KA.

Authors:  Suqing Sun; Peng Wang; Lijie Ren; Hongli Wang; Yanli Zhan; Shimin Shan
Journal:  Onco Targets Ther       Date:  2021-05-20       Impact factor: 4.147

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.